Gaps and barriers between numbers of persons with HIV preexposure prophylaxis (PrEP) indications and those prescribed PrEP are substantial in the US, especially among persons in female, black, and Hispanic populations. This according to a new CDC report that analyzed 2014‒2016 data to estimate the number of persons prescribed PrEP (users) in the US and to describe their demographic characteristics, including race/ethnicity. Researchers found:
- In 2016, among 78,360 persons who filled prescriptions for PrEP in the US, women accounted for only 4.7%.
- Among PrEP users with available data, 68.7%, 11.2%, 13.1%, and 4.5% were white, black, Hispanic, and Asian, respectively.
- ~7% of the estimated 1.1 million persons who had indications for PrEP were prescribed PrEP in 2016.
- Focused efforts are needed to increase the impact of PrEP in the US.
Huang YA, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. MMWR Morb Mortal Wkly Rep. 2018;67:1147–1150. doi:10.15585/mmwr.mm6741a3.
This Week's Must Reads
AHA Statement: Accurate Measurement of BP, Hypertension; ePub 2019 Mar 4; Muntner, et al
Coffee Consumption & Plasma Biomarkers, Am J Clin Nutr; ePub 2019 Mar 5; Hang, et al
Is Adding Aspirin to Warfarin Therapy Beneficial? , JAMA Intern Med; ePub 2019 Mar 4; Schaefer, et al
Must Reads in Infectious Diseases
Invasive GBS Infections in Nonpregnant US Adults, JAMA Intern Med; ePub 2019 Feb 18; Francois Watkins, et al
Enterovirus in at-risk children associated with later celiac disease, Kahrs CR et al. BMJ. 2019 Feb 13. doi: 10.1136/bmj.l231
Prescribed Opioids & Risk of CAP in Patients with HIV, JAMA Intern Med; 2019 Jan 7; Edelman, et al